Cargando…

The thrombopoietin receptor: revisiting the master regulator of platelet production

Thrombopoietin (TPO) and its receptor, MPL, are the primary regulators of platelet production and critical for hematopoietic stem cell (HSC) maintenance. Since TPO was first cloned in 1994, the physiological and pathological roles of TPO and MPL have been well characterized, culminating in the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hitchcock, Ian S., Hafer, Maximillian, Sangkhae, Veena, Tucker, Julie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Special Review Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292222/ https://www.ncbi.nlm.nih.gov/pubmed/34097561 http://dx.doi.org/10.1080/09537104.2021.1925102

Ejemplares similares

Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production
por: Cho, Jooyoung, et al.
Publicado: (2018)

In and out: Traffic and dynamics of thrombopoietin receptor
por: Roy, Anita, et al.
Publicado: (2021)

Cytosolic and mitochondrial Ca(2+) signaling in procoagulant platelets
por: Millington-Burgess, Sarah L., et al.
Publicado: (2021)

Thrombopoietin and its receptor in normal and neoplastic hematopoiesis
por: Kaushansky, Kenneth
Publicado: (2016)

Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021)

Thrombopoietin participates in platelet activation in COVID-19 patients
por: Lupia, Enrico, et al.
Publicado: (2022)

Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
por: Nilles, Kathy M., et al.
Publicado: (2019)

P1666: EFFECT OF AGONISTS TO THROMBOPOIETIN RECEPTORS ON PLATELET GLYCOME OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA
por: Monzón Manzano, E., et al.
Publicado: (2022)

Megakaryocyte/platelet-derived TGF-β1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver
por: Gostynska, Sandra, et al.
Publicado: (2022)

Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin
por: Evstatiev, Rayko, et al.
Publicado: (2014)

Thrombopoietin levels in Quebec platelet disorder—Implications for the mechanism of thrombocytopenia
por: Hayward, C. P. M., et al.
Publicado: (2018)

Thrombopoietin and collagen in low doses cooperatively induce human platelet activation
por: Doi, Tomoaki, et al.
Publicado: (2022)

Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice
por: Eaton, Nathan, et al.
Publicado: (2022)

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia
por: González-Porras, José R., et al.
Publicado: (2019)

Rethinking Meta-Analysis: Applications for Air Pollution Data and Beyond
por: Goodman, Julie E, et al.
Publicado: (2015)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
por: Nakai, Kensaku, et al.
Publicado: (2022)

Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists
por: Gilreath, Jeffrey, et al.
Publicado: (2021)

Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
por: Rauber, Philip, et al.
Publicado: (2018)

Thrombopoietin knock-in augments platelet generation from human embryonic stem cells
por: Zhang, Leisheng, et al.
Publicado: (2018)

Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus
por: Bosco, Ornella, et al.
Publicado: (2021)

Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review
por: Agarwal, Nikki, et al.
Publicado: (2021)

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
por: Motta, Juliana Maria, et al.
Publicado: (2023)

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
por: Garzon, Angelica Maria, et al.
Publicado: (2015)

Thrombopoietin receptor is required for the oncogenic function of CALR mutants
por: Nivarthi, H, et al.
Publicado: (2016)

Platelet Turnover in Stable Coronary Artery Disease – Influence of Thrombopoietin and Low-Grade Inflammation
por: Larsen, Sanne Bøjet, et al.
Publicado: (2014)

Immature Platelet Counts and Thrombopoietin Plasma Concentrations in Thrombocytopenic and Non-thrombocytopenic Preterm Infants
por: Sallmon, Hannes, et al.
Publicado: (2021)

Revisiting the Master-Signifier, or, Mandela and Repression
por: Hook, Derek, et al.
Publicado: (2016)

Gossypiboma revisited: A never ending issue
por: Rabie, M. Ezzedien, et al.
Publicado: (2015)

Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin
Publicado: (1996)

Overproduction of thrombopoietin by BRAFV600E‐mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis
por: Tanaka, Hiroki, et al.
Publicado: (2019)

Thrombopoietin Receptor Levels in Tumor Cell Lines and Primary Tumors
por: Erickson-Miller, Connie L., et al.
Publicado: (2010)

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
por: Spivak, Jerry L., et al.
Publicado: (2021)

Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers
por: Venkatesan, Arunkumar, et al.
Publicado: (2021)

Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
por: Shin, Jiwon, et al.
Publicado: (2023)

The de Winter’s pattern revisited: a case series
por: John, Thadathilankal-Jess, et al.
Publicado: (2020)

Revisiting the forgotten remnant: Imaging spectrum of Meckel’s diverticulum
por: Kumar, Manish, et al.
Publicado: (2022)

Confidence limits, error bars and method comparison in molecular modeling. Part 1: The calculation of confidence intervals
por: Nicholls, A.
Publicado: (2014)

Health human resources planning in Canada—Part I: Opportunities and challenges for pharmacy
por: Austin, Zubin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p4mqr2suduv6vdaklbi7i2dh6t